Oral Pathology pp 147-177 | Cite as

Importance of Proliferation Markers in Oral Pathology

  • K. A. A. S. Warnakulasuriya
  • N. W. Johnson
Part of the Current Topics in Pathology book series (CT PATHOLOGY, volume 90)

Abstract

Disturbances in growth, including the carcinogenic process, are often linked with an increased rate of cell proliferation, usually combined with sustained hyperplasia (Iverson 1992). As a result, over the past three decades, there has been considerable interest in markers of cell proliferation that can be used as indicators of the clinical aggressiveness of human neoplasms, additional to what can be judged from histology alone. The hope is that such markers will have value in prognosis and treatment planning. It is necessary at the outset to understand that the significance of “proliferative activity” depends on the number of cells undergoing programmed cell death or apoptosis (Wyllie 1993) in a given compartment of cells. Aspects of cell proliferation have, however, been studied more extensively, and data taking apoptosis into account are limited. In this chapter we review, mainly in quantitative terms, the major parameters useful in understanding the kinetics of cell proliferation and look critically at the methodology used, with particular reference to epithelial systems and to oral mucosal disease. Data derived from many studies examining the cell kinetics of both oral and some other head and neck malignancies (particularly squamous cell carcinomas, SCC), potentially malignant lesions of the oral mucosa and a few other oral diseases of interest are presented. The usefulness of such investigations in understanding the pathogenesis of oral diseases and their potential value as diagnostic and prognostic markers in the discipline of oral pathology is addressed.

Keywords

Adenoma Oncol Galle Gelatin Candida 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aherne WA, Dunhill MS (1982) Morphometry. Arnold, London, pp 46–59Google Scholar
  2. Aherne WA, Camplejohn RS, Al-Wiswazy M, Ford D, Kellerer M (1977) Assessment of inherent fluctuations of mitotic and labelling indices of human tumours. Br J Cancer 36: 577–591PubMedGoogle Scholar
  3. Alcalde RE, Shintani S, Yoshihama Y, Matsumura T (1995) Cell proliferation and tumor angiogenesis in oral squamous cell carcinoma. Anticancer Res 15: 1417–1422PubMedGoogle Scholar
  4. Alvares O, Skougaard MR, Pindborg JJ, Roed-Petersen B (1972) In vitro incorporation of tritiated thymidine in oral homogeneous leukoplakias. Scand J dent Res 80: 510–514PubMedGoogle Scholar
  5. Baak JPA (1990) Mitosis counting in tumours. Hum Pathol 21: 683–685PubMedGoogle Scholar
  6. Baak JPA, van Dep H, Kurver PHJ, Hermans J (1985) The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374–382PubMedGoogle Scholar
  7. Baak JPA, Wise-Brekelmans ECM, Langley FA, Talerman A, Delamarre JFM (1986) Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours. J Clin Pathol 39: 1340–1346PubMedGoogle Scholar
  8. Balsara BR, Borges AM, Pradhan SA, Rajpal RM, Bhisey AN (1994) Flow cytometric DNA analysis of squamous cell carcinomas of the oral cavity: correlation with clinical and histopathological features. Oral Oncol Eur J Cancer 30: 98–101Google Scholar
  9. Bang G, Donath K, Thoresen S, Clausen OP (1994) DNA flow cytometry of reclassified subtypes of malignant salivary gland tumors. J Oral Pathol Med 23: 291–297PubMedGoogle Scholar
  10. Barnes DM, Gillett CE (1995) Determination of cell proliferation. J Clin Pathol Mol Pathol 48: M2 - M5Google Scholar
  11. Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J (1995) Abnormal patterns of D-type cyclin expression and G, regulation in human head and neck cancer. Cancer Res 55: 949–956PubMedGoogle Scholar
  12. Begg AC, McNally NJ, Shrieve DC, Karcher H (1985) A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620PubMedGoogle Scholar
  13. Benazzo M, Mevio E, Occhini A, Franchini G, Danova M (1995) Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry. J Otorhinolaryngol Relat Spec 57: 39–43Google Scholar
  14. Bennett MH, Wilson GD, Dische S, Saunders MI, Martindale CA, Robinson BM, O’Halloran AE, Leslie MD, Laing JHE (1992) Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 65: 870–878PubMedGoogle Scholar
  15. Berlingin E, Heenen M, Galand P (1992) Measurement of S phase duration in human epidermis using cyclin immunostaining and 3H-thymidine pulse labelling. Arch Dermatol Res 284: 238–241PubMedGoogle Scholar
  16. Bettinger R, Loerz M, Meyer-Breiting E (1991) Proliferative activity following induction chemotherapy in squamous cell carcinoma of the head and neck. A histopathological and immunohistochemical study using monoclonal antibodies. Eur Arch Otorhinolaryngol 248: 236–241Google Scholar
  17. Birck C, Lui E, Jordan RCK, Dardick I (1994) Analysis of c-erbB-2 amplification in salivary gland tumours by differential polymerase chain reaction. Oral Oncol Eur J Cancer 30: 47–50Google Scholar
  18. Bourhis J, Bosq J, Wilson GD, Bressac B, Talbot M, Leridant AM, Dendale R, Janin N, Armand JP, Luboinski B, Malaise EP, Wibault P, Eschwege F (1994a) Correlation between p53 gene expression and tumor-cell proliferation in orophayngeal cancer. Int J Cancer 57: 458–462PubMedGoogle Scholar
  19. Bourhis J, Wilson G, Wibault P, Janot F, Bosq J, Armand JP, Luboinski B, Malaise EP, Eschwege F (1994b) Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer. Laryngoscope 104: 468–472PubMedGoogle Scholar
  20. Bravo R, MacDonald-Bravo H (1985) Changes in the nuclear distribution of cyclin ( PCNA) but not its synthesis depend upon DNA replication. EMBO J 4: 655–661PubMedGoogle Scholar
  21. Bresciani F, Paoluzi R, Benassi M, Nervi C, Casale C, Ziparo E (1974) Cell kinetics and growth of squamous cell carcinomas in man. Cancer Res 34: 2405–2415PubMedGoogle Scholar
  22. Britto MJ, Filipe MI, Morris RW (1992) Cell proliferation study on gastric carcinoma and non involved gastric mucosa using bromodeoxyuridine ( Brd U) labelling technique. Eur J Can Prey 1: 429–435Google Scholar
  23. Browman GP, Kanclerz A, Booker L, Daya D, Archibald SD, Young JEM, Goldsmith CH (1991) Optimal concentration for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer. Cell Prolif 24: 579–585PubMedGoogle Scholar
  24. Bryne M, Nielsen K, Koppang HS, Dabelsteen E (1991) Reproducibility of two malignancy grading systems with reportedly prognostic value for oral cancer patients. J Oral Pathol Med 20: 369–372PubMedGoogle Scholar
  25. Burkhardt A (1985) Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa. J Oral Pathol 14: 751–778PubMedGoogle Scholar
  26. Cabrini RL, Schwint AE, Mendex A, Femopase F, Lanfranchi H, Itoiz ME (1992) Morphometric study of nucleolar organizer regions in human oral normal mucosa, papilloma and squamous cell carcinoma. J Oral Pathol Med 21: 275–279PubMedGoogle Scholar
  27. Cardillo MR (1991) Ag-NOR technique in fine needle aspiration cytology of salivary gland masses. Acta Cytol 36: 147–151Google Scholar
  28. Cattoretti G, Becker MHG, Key G, Duchrow M, Schulter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J Pathol 168: 357–363PubMedGoogle Scholar
  29. Chattopadhyay A, Chawda JG, Doshi JJ (1994) Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma. Int J Oral Maxillofac Surg 23: 374–377PubMedGoogle Scholar
  30. Chauvel P, Courdi A, Gioanni J, Vallicioni J, Santini J, Demard F (1989) The labelling index: a prognostic factor in head and neck carcinoma. Radiother Oncol 14: 231–237PubMedGoogle Scholar
  31. Chen RB, Suzuki K, Nomura T, Nakajima T (1993) Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymphnode metastasis. J Oral Maxillofax Surg 51: 397–401Google Scholar
  32. Chomette GP, Auriol MM, Labrousee F, Vaillant JM (1991) Mucoepidermoid tumors of salivary glands: histoprognostic value of NORs stained with AgNOR technique. J Oral Pathol Med 20: 130–132PubMedGoogle Scholar
  33. Chungpanich S, Smith CJ (1989) Nucleolar organizer regions ( NORs) in hyperplastic lesions and squamous cell carcinomas of the oral mucosa. J Dent Res 68: 579Google Scholar
  34. Clurman BE, Roberts JM (1995) Cell cycle and cancer. J Nat Cancer Inst 87: 1499–1501PubMedGoogle Scholar
  35. Collan Y, Kunpusalo L, Pesonen E, Eskelinen M, Pajarinen P, Kettumen K (1988) Prediction of prognosis of breast cancer: multivariate analysis of mitotic index, lymph node status and tumour size. Acta Clinic Med 174: 8 (abstract)Google Scholar
  36. Criscuolo M, Malagoli G, Falchi AM, Ancora M, Ancora R, De Pol A (1989) Kinetic features of the oral cavity epithelium in leukoplakia. Cell Tissue Kinet 22: 137Google Scholar
  37. Crocker J, Boldy DAR, Egan MJ (1989) How should we count AgNOR’s? Proposals for a standardized approach. J Pathol 158: 185–188PubMedGoogle Scholar
  38. Cross SS, Start RD, Smith JHF (1990) Does delay in fixation affect the number of mitotic figures in processed tissue. J Clin Pathol 43: 597–599PubMedGoogle Scholar
  39. Egan MJ, Crocker J (1992) Nucleolar organiser regions in pathology. Br J Cancer 65: 1–7PubMedGoogle Scholar
  40. El-Labban N, Lucas RB, Kramer IRH (1971) The mitotic values for the epithelium in oral keratoses and lichen planus. Br J Cancer 25: 411–416PubMedGoogle Scholar
  41. Ellis SJ, Whitehead R (1981) Mitoses counting: a need for reappraisal. Hum Pathol 12: 3–4PubMedGoogle Scholar
  42. Evans SJ, Langdon JD, Rapidis AD, Johnson NW (1982) Prognostic significance of STNMP and velocity of tumor growth in oral cancer. Cancer 49: 773–776PubMedGoogle Scholar
  43. Eversole LR, Sapp JP (1993) c-myc oncoprotein expression in oral precancerous and early cancerous lesions. Oral Oncol Eur J Cancer 29: 131–136Google Scholar
  44. Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP (1989) Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 4: 1463–1468PubMedGoogle Scholar
  45. Forster G, Cooke TG, Cooke LD, Stanton PD, Bowie G, Stell PM (1992) Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 65: 698–702PubMedGoogle Scholar
  46. Galand P, Degraef C (1989) Cyclin/PCNA immunostaining as an alterative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22: 383–392PubMedGoogle Scholar
  47. Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JRC, Meli S, Boracchi P, Testolin A, La Malfa G, Pozza F (1992) Human breast cancer: prognostic significance of the c-erbB-2 oncoprotien compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. J Clin Oncol 10: 686–695PubMedGoogle Scholar
  48. Gee JMW, Douglas-Jones A, Hepburn P, Sharma AK, McClelland RA, Ellis IO, Nicholson RI (1995) A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers. J Pathol 177: 285–293PubMedGoogle Scholar
  49. Gerdes J, Levike H, Baisch H, Walker HH, Schwab V, Stein H (1984) Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133: 1710–1715PubMedGoogle Scholar
  50. Gillett CE, Smith P, Camplejohn RS, Mills RR (1993) Mitotic activity index - a useful marker of prognosis in breast carcinoma. J Pathol 169: 199 (abstract)Google Scholar
  51. Girod SC, Pape HD, Krueger GRF (1994) P53 and PCNA expression in carcinogenesis of the oropharyngeal mucosa. Oral Oncol Eur J Cancer 30: 419–423Google Scholar
  52. Girod SC, Leitner I, Fischer U, Junk M, Krueger GRF (1995) P53 overexpression and cell proliferation as prognostic markers in oral cancer. In: Varma AK, Mori M (eds) Oral oncology, vol IVB. Macmillan India, pp 3–7.Google Scholar
  53. Goldsmith MM, Gresson DH, Arnold LA, Postma DS, Askin FB, Pillsbury HC (1987) DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 96: 307–318PubMedGoogle Scholar
  54. Grässel-Pietrusky R, Deinlein E, Hornstein OP (1982) DNA-ploidy rates in oral leukoplakias determined by flow-cytometry. J Oral Pathol 11: 434–438PubMedGoogle Scholar
  55. Gratzner HG (1982) Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218: 474–475PubMedGoogle Scholar
  56. Günzl HJ, Horn H, Schücke R, Donath K (1993) Prognostic value of PCNA and cytokeratins for radiation therapy of oral squamous cell carcinoma. Oral Oncol Eur J Cancer 29B: 141–145Google Scholar
  57. Haapasalo H, Collen Y, Atkin NB, Pesonen E, Seppa A (1989) Prognosis of ovarian carcinomas: prediction of histo quantitative methods. Histopathology 15: 167–168PubMedGoogle Scholar
  58. Hall PA, Levison DA (1990) Assessment of cell proliferation in histological material. J Clin Pathol 43: 184–192PubMedGoogle Scholar
  59. Hall PA, Woods AL (1990) Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet 23: 505–522PubMedGoogle Scholar
  60. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillet GE, Camplejohn R, Dover R, Waseman NH, Lane DP (1990) Proliferating cell nuclear antigen (PCNA) immunologicalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285–294PubMedGoogle Scholar
  61. Hall PA, Hart I, Goodlad R, Coates PJ, Lane DP (1992) Expression of proliferating cell nuclear antigen in non-cycling cells. J Pathol 168: 97A (abstract)Google Scholar
  62. Hamilton PW, Allen DC (1995) Morphometry in histology. J Pathol 175: 369–379PubMedGoogle Scholar
  63. Hamper K, Lazar F, Dietel M, Caslitz J, Berger J, Arps H, Falkmer U, Auer G, Seifert G (1990) Prognostic factors for adenoid carcinoma of the head and neck: a retrospective evaluation of 96 cases. J Oral Pathol Med 19: 101–107PubMedGoogle Scholar
  64. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333–1335PubMedGoogle Scholar
  65. Hemmer J (1990) In vitro bromodeoxyuridine labelling of squamous cell carcinomas of the oral cavity. Eur J Cancer 26: 113–115PubMedGoogle Scholar
  66. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA (1994) Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91: 709–713PubMedGoogle Scholar
  67. Hoyer M, Bentzen SM, Salling LN, Overgaard J (1994) Influence of sampling time on assessment of potential doubling time. Cytometry 16: 144–151PubMedGoogle Scholar
  68. Hume WJ (1981) A theoretical consideration of some biological parameters involved in cell kinetic investigations of oral leukoplakia and abnormal states in stratified squamous epithelium. J Oral Pathol 10: 375–385PubMedGoogle Scholar
  69. Hunter T (1993) Oncogenes and cell proliferation. Current Opinion Gene Devel 3: 1–4Google Scholar
  70. Ivan GI, Littlewood TD (1993) The role of c-myc in cell growth. Curr Opin Gene Dev 3: 44–49Google Scholar
  71. Iverson OH (1992) Role of cell proliferation in carcinogenesis: is increased cell proliferation in itself a carcinogenic hazard. In: Iverson OH (ed) New frontiers in cancer causation. Taylor and Francis. Washington, pp 97–107Google Scholar
  72. Johnson NW (1976) The role of histopathology in diagnosis and prognosis of oral squamous cell carcinoma. Proc R Soc Med 69: 740–747PubMedGoogle Scholar
  73. Johnson NW, Ranasinghe AW, Warnakulasuriya KAAS (1993) Potentially malignant lesions and conditions of the mouth and oropharynx: natural history–cellular and molecular markers of risk. Eur J Cancer Prey 2: 31–51Google Scholar
  74. Johnson NW, Warnakulasuriya KAAS, Tavassoli M (1996) Hereditary and environmental risk factors: clinical and laboratory risk markers for oral cancer and precancer. Eur J Cancer Prey 5: 5–17Google Scholar
  75. Jones AS (1994) Prognosis in mouth cancer: tumour factors. Oral Oncol, Eur J Cancer 30: 8–15Google Scholar
  76. Jones AS, Roland NJ, Caslin AW, Cooke TG, Cooke LD, Forster G (1994) A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J Laryngol Otol 108: 859–864PubMedGoogle Scholar
  77. Kahn MA, Dockter ME, Hermann-Petrin JM (1992) Flow cytometer analysis of oral premalignant lesions: a pilot study and review. J Oral Pathol Med 21: 1–6PubMedGoogle Scholar
  78. Kamath VV, Sastry KARH (1994) Nucleolar organizer regions ( NORs) in oral lesions. Indian J Oral Pathol 1: 1–11Google Scholar
  79. Kearsley JH, Thomas S (1993) Prognostic markers in cancers of the head and neck region. Anti Cancer Drugs 4: 419–429PubMedGoogle Scholar
  80. Kearsley JH, Furlong KL, Cooke PA, Waters MJ (1990) An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell carcinoma. Br J Cancer 61: 821–827PubMedGoogle Scholar
  81. Kernohan NM, Blessing K, King G, Corbett IP, Miller ID (1991) Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study. J Pathol 163: 77–80PubMedGoogle Scholar
  82. Kramer IRH, Lucas RB, El-Labban N, Lister L (1970) The use of discriminant analysis for examining the histological features of oral keratoses and lichen planus. Br J Cancer 24: 673–686PubMedGoogle Scholar
  83. Lambert M (1986) Tritiated thymidine labelling in vitro for human cancer of the breast: counting error and sampling error. Eur J Cancer Clin Oncol 22: 781–785PubMedGoogle Scholar
  84. Landini G (1990) Nucleolar organizing regions (NORs) in pleomorphic adenomas of the salivary glands. J Oral Pathol Med 19: 257–260PubMedGoogle Scholar
  85. Li TJ, Browne RM, Matthews JB (1994) Quantification of PCNA’ cells within odontogenic jaw cyst epithelium. J Oral Pathol Med 23: 184–189PubMedGoogle Scholar
  86. Li TJ, Browne RM, Matthews JB (1995a) Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome ( BCNS)-associated lesions. J Oral Pathol Med 24: 221–226PubMedGoogle Scholar
  87. Li TJ, Browne RM, Matthews JB (1995b) Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology 26: 219–228PubMedGoogle Scholar
  88. Lochrin CA, Wilson GD, McNally NJ, Dische S, Saunders MI (1992) Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int J Radiat Oncol Biol Phys 24: 87–91PubMedGoogle Scholar
  89. Lombardi T, Morgan PR (1994) Comparison of PCNA and P34ado in the epithelium of odontogenic cysts. Proceedings of the VIIth international association of oral pathologists, York p 30, abstract no P38Google Scholar
  90. Lörz M, Meyer-Breiting E, Bettinger R (1994) Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer. Eur Arch Otorhinolaryngol 251: 91–94PubMedGoogle Scholar
  91. Maidhof R, Hornstein OP (1979) Autoradiographic study on some proliferative properties of human buccal mucosa. Arch Dermatol Res 265: 165–172PubMedGoogle Scholar
  92. Main DMG (1965) Mitotic activity in buccal keratoses. J Dent Res 44: 1182Google Scholar
  93. Matsumua K, Sasaki K, Tsuji T, Shirozaki F (1989) Nucleolar organizer regions associated proteins ( AgNORs) in salivary gland tumors. Int J Oral Maxillofac Surg 18: 76–78Google Scholar
  94. Miller WR (1992) Prognostic factors in breast cancer. Br J Cancer 66: 775–776PubMedGoogle Scholar
  95. Molinari R, Costa A, Veneroni S, Mattavelli F, Salvatori P, Silvestrini R (1991) Cell kinetics and response to primary intra-arterial chemotherapy in patients with advanced oral cavity tumors. J Oral Pathol Med 20: 32–36PubMedGoogle Scholar
  96. Morgan DO (1992) Cell cycle control in normal and neoplastic cells. Curr Opin Genet Dev 2: 33–37PubMedGoogle Scholar
  97. Morgan DW, Crocker J, Watts A, Shenoi PM (1988) Salivary gland tumors studied by means of AgNOR technique. Histopathology 13: 553–560PubMedGoogle Scholar
  98. Murakami M, Ohtani I, Hojo H, Wasaka H (1992) Immunohistochemical evaluation with Ki-67: an application to salivary gland tumours. J Laryngol Otol 106: 35–38PubMedGoogle Scholar
  99. Nylander K, Anneroth G, Gustafsson H, Roos G, Stenling R, Zackrisson B (1994a) Cell kinetics of head and neck squamous cell carcinomas. Acta Oncol 33: 23–28PubMedGoogle Scholar
  100. Nylander K, Sterling R, Gustafsson H, Ross G (1994b) Application of dual parameter analysis in flow cytometric DNA assessments of paraffin-embedded samples. J Oral Path Med 28: 190–192Google Scholar
  101. Ogawa I, Miyauchi M, Takata T, Vuhahula E, Ijuhin N, Nikai H (1993) Proliferative activity of salivary gland pleomorphic adenomas and myoepitheliomas as evaluated by the proliferating cell nuclear antigen (PCNA) labeling index ( LI ). J Oral Pathol Med 22: 447–450PubMedGoogle Scholar
  102. Pich A, Chiusa L, Pisani P, Krengli M, Pia F, Navone R (1992) Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. J Cancer Res Clin Oncol 119: 106–110PubMedGoogle Scholar
  103. Pilgrim C, Erb W, Maurer W (1963) Diurnal fluctuations in the number of DNA synthesizing nuclei in various mouse tissues. Nature 199: 863PubMedGoogle Scholar
  104. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ (1986) Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organiser region at the optical level. Histochem J 18: 5–14PubMedGoogle Scholar
  105. Pollack A, Terry NH, Wu CB, Wise BM, White RA, Meistrich ML (1995) Specific staining of iododeoxyuridine and bromodeoxyuridine in tumours double labelled in vitro: a cell kinetic analysis. Cytology 20: 61–63Google Scholar
  106. Pusztai L, Lewis CE, Lorenzen J, McGee JO’D (1993) Growth factors: regulation of normal and neoplastic growth. J Pathol 169: 191–201PubMedGoogle Scholar
  107. Quinn CM, Wright NA (1990) The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 160: 93102Google Scholar
  108. Rajendran R, Nair SM (1992) Silver binding nucleolar organiser region proteins as a possible prognostic markers in oral submucous fibrosis. Oral Surg 74: 481–486PubMedGoogle Scholar
  109. Randall MB, Geisinger KR, Kute TE, Buss DH, Prichard RW (1990) DNA content and proliferative index in cutaneous squamous-cell carcinoma and keratoacanthoma. Am J Clin Pathol 93: 259–262PubMedGoogle Scholar
  110. Rennie JS, MacDonald DG, Warnakulasuriya KAAS (1984) Oral epithelial cell kinetics: evaluation of an in vitro method of study. Med Lab Sci 41: 121–126PubMedGoogle Scholar
  111. Renstrup G (1963) Studies in oral leukoplakias. IV. Mitotic activity in oral leukoplakias. A preliminary report. Acta Odontol Scand 21: 333–340PubMedGoogle Scholar
  112. Roland NJ, Caslin AW, Bowie GL, Jones AS (1994) Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol 19: 13–18PubMedGoogle Scholar
  113. Ruschoff J, Plate KH, Contractor H, Kern S, Zimmerman R, Thomas C (1990) Evaluation of nucleolus organizer regions (NORS) by automatic image analysis. A contribution to standarization. J Pathol 161: 113–118PubMedGoogle Scholar
  114. Saito T, Notani K-I, Miura H, Fukuda H, Mizuno S, Shindoh M, Amemiya A (1991) DNA analysis of oral leukoplakia by flow cytometry. Int J Oral Maxillofaci Surg 20: 259–263Google Scholar
  115. Sakuma J (1980) Cell kinetics of human squamous cell carcinoma in the oral cavity. Bull Tokyo Med Dent Univ 27: 43–54PubMedGoogle Scholar
  116. Sano K, Takahashi H, Fujita S, Inokuchi T, Pe MB, Okabe H, Tsuda N (1991) Prognostic implication of silver-binding nucleolar organizer regions ( AgNORS) in oral squamous cell carcinoma. J Oral Pathol Med 20: 53–56PubMedGoogle Scholar
  117. Sardella A, Abati S, Carrassi A (1991) Valutazione dell-attivita proliferativa del lichen planus orale. Minerva Stomatol 40: 557–561PubMedGoogle Scholar
  118. Schneider C, Gustincich S, Del Sal G (1991) The complexity of cell proliferation control in mammalian cells. Curr Opin Cell Biol 3: 276–281PubMedGoogle Scholar
  119. Scott N, Cross D, Plumb MI, Dixon MF, Quirke P (1992) An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer. Br J Cancer 65: 8–10PubMedGoogle Scholar
  120. Scott RJ, Hall PA, Haldane JS, Price Y, Van Noorden S, Price Y, Lane DP, Wright NA (1991) A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165: 173–178PubMedGoogle Scholar
  121. Scragg MA, Johnson NW (1980a) Epithelial cell kinetics - a review of methods of study and their application to oral mucosa in health and disease. A. Methods for studying cell proliferation and some sources of variation. J Oral Pathol 9: 309–341PubMedGoogle Scholar
  122. Scragg MA, Johnson NW (1980b) A comparison of in vivo and in vitro stathmokinetic methods for the study of cell proliferation in hamster oral epithelia. Cell Tissue Kinet 13: 359–369PubMedGoogle Scholar
  123. Scragg MA, Johnson NW (1982) Epithelial cell kinetics. A review of methods of study and their application to oral mucosa in health and disease. B. Comparison of cell kinetics in normal and abnormal epithelia. J Oral Pathol 11: 102–137PubMedGoogle Scholar
  124. Scully C (1993) Oncogenes, tumour suppressors and viruses in oral squamous carcinoma. J Oral Pathol Med 22: 337–347PubMedGoogle Scholar
  125. Seifert G (1992) Histopathology of malignant salivary gland tumours. Oral Oncol Eur J Cancer 28: 49–56Google Scholar
  126. Shrestha P, Huang JW, Tsuji T, Shinozaki F, Maeda K, Sasaki K, Ueno K, Yamada K, Mori M (1992) Rare expression of the c-erbB-2 oncoprotein in salivary gland tumors: an immunohistochemical study. J Oral Pathol Med 21: 477–480PubMedGoogle Scholar
  127. Sickle-Santanello BJ, Farrar WB, Dobson JL, O’Toole RV, Keyhani-Rofagha S (1986) Flow cytometric analysis of DNA content as a prognostic indicator in squamous cell carcinoma of the tongue. Am J Surg 152: 393–395PubMedGoogle Scholar
  128. Silvestrini R (1994) Cell kinetics: prognostic and therapeutic implications in human tumours. Cell Prolif 27: 579–596Google Scholar
  129. Silvestrini R, Molinari R, Costa A. Volterrani F, Gardani G (1984) Short-term variation in labeling index as a predictor of radiotherapy response in human oral cavity carcinoma. J Radiat Oncol Biol Phys 10: 965–970Google Scholar
  130. Silvestrini R, Costa A, Veneroni S, Del Bino G, Persici P (1988) Comparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet 21: 123–131PubMedGoogle Scholar
  131. Slootweg PJ (1995) p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 24: 393–397PubMedGoogle Scholar
  132. Slootweg PJ, Koole R, Hordijk GJ (1994) The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Oral Oncol Eur J Cancer 30: 138–141Google Scholar
  133. Smith C, Pindborg JJ (1969) Histological grading of oral epithelial atypia by the use of photographic standards. Hamburgers Bogtrykkeri, Copenhagen, pp 1–35Google Scholar
  134. Stanton PD, Oakes SJ, McArdle CS, Forster G, Cooke TG (1991) Reliability of flow cytometric measurements of cell kinetics. Br J Surg 78: 750 (abstract)Google Scholar
  135. Steinbeck RG, Moege J, Heselmeyer KM, Klebe W, Neugebauer W, Borg B, Auer GU (1993) DNA content and PCNA immunoreactivity in oral precancerous and cancerous lesions. Oral Oncol Eur J Cancer 29B: 279–284Google Scholar
  136. Steel GG (1977) Growth kinetics of tumours. Clarendon, OxfordGoogle Scholar
  137. Störkel S, Reichert T, Reiffen KA, Wagner W (1993) EGFR and PCNA expression in oral squamous cell carcinomas–a valuable tool in estimating the patient’s prognosis. Oral Oncol Eur J Cancer 29B: 273–277Google Scholar
  138. Sugerman PB, Joseph BK, Savage NW (1995) The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation. Oral Dis 1: 172–188PubMedGoogle Scholar
  139. Suzuki K, Chen RB, Nomura T, Nakajima T (1994) Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral and maxillofacial region. J Oral Maxillofac Surg 52: 855–861PubMedGoogle Scholar
  140. Toiler PA (1971) Autoradiography of explants from odontogenic cysts. Br Dent J 131: 57–61Google Scholar
  141. Tsai ST, Jin YT (1995) Proliferating cell nuclear antigen ( PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 24: 313–315PubMedGoogle Scholar
  142. Tsuji T, Shrestha P, Yamada K, Takagi H, Shinozaki F, Sasaki K, Maeda K, Mori M (1992). Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study. Virchows Arch [Al Pathol Anat 420: 377–383Google Scholar
  143. Tytor M, Franzén G, Olofsson J (1987) DNA pattern in oral cavity carcinomas in relation to clinical stage and histological grading. Pathol Res Pract 182: 202–206PubMedGoogle Scholar
  144. Underwood JCE, Giri DD (1988) Nucleolar organiser regions as diagnostic discriminants of malignancy. J Pathol 155: 95–96 (editorial)Google Scholar
  145. van Heerden WFP, Raubenheimer EJ (1991) Evaluation of the nucleolar organizer region associated proteins in minor salivary gland tumours. J Oral Pathol Med 20: 291–295PubMedGoogle Scholar
  146. van Heerden WFP, Raubenheimer EJ, van Rensburg EJ, le Roux R (1995) Lack of correlation between DNA ploidy, Langerhans cell population and grading in oral squamous cell carcinoma. J Oral Pathol Med 24: 61–65PubMedGoogle Scholar
  147. Walker DM, Dolby AE (1974) Labelling index in the mucosal lesions of lichen planus. Br J Dermatol 91: 549–556PubMedGoogle Scholar
  148. Walker RA, Camplejohn RS (1988) Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 57: 281–283PubMedGoogle Scholar
  149. Warnakulasuriya KAAS (1976) Cell proliferation of human oral mucosa. PhD thesis, University of GlasgowGoogle Scholar
  150. Warnakulasuriya KAAS, Johnson NW (1993a) Comparison of isotopic and immunohistochemi- cal methods of studying cell proliferation in hamster tongue. Cell Prolif 26: 545–555PubMedGoogle Scholar
  151. Warnakulasuriya KAAS, Johnson NW (1993b) Nucleolar organiser region ( NOR) distribution as a diagnostic marker in oral keratosis, dysplasia and squamous cell carcinoma. J Oral Pathol Med 22: 77–81PubMedGoogle Scholar
  152. Warnakulasuriya KAAS, Johnson NW (1994) Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med 23: 246–250PubMedGoogle Scholar
  153. Warnakulasuriya KAAS, MacDonald DG (1993) Diurnal variation in labelling index in human buccal epithelium. Arch Oral Biol 38: 1107–1111PubMedGoogle Scholar
  154. Warnakulasuriya KAAS, MacDonald DG (1995a) The influence of rate of cell entry to S phase on the labelling index of human buccal epithelium. Arch Oral Biol 40: 107–110PubMedGoogle Scholar
  155. Warnakulasuriya KAAS, MacDonald DG (1995b) Epithelial cell kinetics in oral leukoplakia. J Oral Pathol Med 24: 165–169PubMedGoogle Scholar
  156. Warnakulasuriya KAAS, Ahmed MS, Penhallow J, Johnson NW (1994) Increased cell proliferation and dysplasia in candida associated oral keratoses. Proceedings of the VIIth international association of oral pathologists, York meeting, abstract no PO6Google Scholar
  157. Waseem NH, Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96: 121–129PubMedGoogle Scholar
  158. Welsgerber VIM, Boeing H, Neunitz R, Ruedasih R, Waldehen R (1993) Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium. Gut 34: 1587–1592Google Scholar
  159. Whitaker SB, Vigneswaran N, Budnick SD, Waldron CA (1993) Giant cell lesions of the jaws: evaluation of nucleolar organizer regions in lesions of varying behavior. J Oral Pathol Med 22: 402–405PubMedGoogle Scholar
  160. Wilson GD (1991) Assessment of human tumour proliferation using bromodeoxyuridine–current status. Acta Oncol 30: 903–910PubMedGoogle Scholar
  161. Wilson GD, McNally NJ, Dunphy E, Karcher H, Pfragner R (1985) The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 6: 641PubMedGoogle Scholar
  162. Wilson GD, McNally NJ, Dische S, Saunders MI, Des Rochers C, Lewis AA, Bennett MH (1988) Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 58: 423–431PubMedGoogle Scholar
  163. Wilson GD, Richman PI, Dische S, Saunders MI, Robinson B, Daley FM, Ross DA (1995) p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy 71: 1248–1252Google Scholar
  164. Wong DTW, Biswas DK (1987) Expression of c-erbB proto-oncogene during dimethylbenzanthracene-induced tumorigenesis in hamster cheek pouch. Oncogene 2: 67–72PubMedGoogle Scholar
  165. Wyllie AH (1993) Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer 67: 205–208PubMedGoogle Scholar
  166. Wynford-Thomas D, Williams ED (1986) Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet 19: 179–182PubMedGoogle Scholar
  167. Yang L, Liu B, Qin C, Hashimura K, Yamada T, Sumitoma S, Mori M (1994) Comparison of proliferating cell nuclear antigen index in benign and malignant salivary pleomorphic adenoma. Oral Oncol Eur J Cancer 30: 56–60Google Scholar
  168. Yu CCW, Woods AL, Levison DA (1992) The application of immunohistochemistry in assessment of cellular proliferation. In: Hall PA, Lawson DA, Wright DA (eds) Assessment of cell proliferation in clinical practice. Springer, Berlin Heidelberg New York, pp 141–157Google Scholar
  169. Zhao FY (1992) Flow cytometric analysis of squamous cell carcinoma of the oral and maxillofacial region. Chung Hua Kou Chiang Hsueh Tsa Chih 27: 222–224PubMedGoogle Scholar
  170. Zoeller J, Flentje M, Sinn P, Born IA (1994) Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas. Anal Cell Pathol 7: 77–88PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • K. A. A. S. Warnakulasuriya
  • N. W. Johnson

There are no affiliations available

Personalised recommendations